Back Estropipat German Estropipato Spanish Estropipato Italian ଏଷ୍ଟ୍ରୋପିପେଟ OR Estropipat Serbo-Croatian Estropipat Serbian Estropipate Vietnamese
 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Harmogen, Improvera, Ogen, Ortho-Est, Sulestrex, others |
| Other names | Piperazine estrone sulfate; Estrone sulfate piperazine salt; Pipestrone |
| AHFS/Drugs.com | Monograph |
| Routes of administration | By mouth |
| Drug class | Estrogen; Estrogen ester |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.027.906 |
| Chemical and physical data | |
| Formula | C22H32N2O5S |
| Molar mass | 436.57 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Estropipate, also known as piperazine estrone sulfate and sold under the brand names Harmogen, Improvera, Ogen, Ortho-Est, and Sulestrex among others, is an estrogen medication which is used mainly in menopausal hormone therapy in the treatment of menopausal symptoms.[2][3][4][5] It is a salt of estrone sulfate and piperazine, and is transformed into estrone and estradiol in the body.[3][4] It is taken by mouth.[2]
- ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
- ^ a b "Ogen, estropipate tablets, USP" (PDF). Pharmacia & Upjohn Co. U.S. Food and Drug Administration. December 2004.
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 900–. ISBN 978-1-4757-2085-3.
- ^ a b Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 114–. ISBN 978-94-011-4439-1.
- ^ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia (3rd ed.). Elsevier. pp. 1484–. ISBN 978-0-8155-1856-3.